MEDFLEX A/S: Financial statements 2021
CVR: 32058116
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
MEDFLEX A/S (CVR 32058116) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 83,858,296 and a net result of DKK 9,334,129 compared with DKK 6,701,832 the year before. That is an increase of 36.7% compared with the year before. Equity in the 2021 report amounted to DKK 11,135,962. The solvency ratio was 38.6%. The company had 51 employees in the financial year.
- Gross Profit
- DKK 83,858,296
- Profit/Loss
- DKK 9,334,129
- Equity
- DKK 11,135,962
- Total Assets
- DKK 28,850,802
- Employees
- 51
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 83.9 mio. | 9.3 mio. | 11.1 mio. | 51 |
| 2020 | - | 61.4 mio. | 6.7 mio. | 7.2 mio. | 39 |
| 2019 | - | 55 mio. | 5.2 mio. | 5.7 mio. | 35 |
| 2018 | - | 65.5 mio. | 5.3 mio. | 5.8 mio. | 44 |
| 2017 | - | 66.4 mio. | 7.3 mio. | 7.8 mio. | 48 |
Official annual report
Find more companies like MEDFLEX A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
MEDFLEX A/S has published its annual report for 2020. Gross profit came to DKK 61,366,058, and the net result was DKK 6,701,832.
As of March 1, 2021, Claus Christian Louring is registered as adm. dir. of MEDFLEX A/S.
As of March 1, 2021, Jakob Damm-Jakobsen has stepped down as director of MEDFLEX A/S.
About MEDFLEX A/S
MEDFLEX A/S was a Danish company of the type Aktieselskab based in Randers SV, founded in 2009. The company has been dissolved on 1 October 2023. The company was registered under the industry Vikarbureauer. The company was previously named MEDFLEX ApS. The company has 204 employees (2023). In 2022, the company reported a gross profit of DKK 84,248,564 and a net result of DKK 6,672,253 compared with DKK 9,334,129 the year before. Equity in the 2022 report amounted to DKK 17,808,216.